“robert-nelsen” Archives

in
Entry Author Date Location
Vir Bio Plans IPO to Fund Clinical Trials of Infectious Disease Drugs 09/03/19 San Francisco
Arch’s Bob Nelsen on Big Biotech and Why Pharma Should Be Very Afraid 05/15/18 National
Scangos Surfaces to Lead New Infectious Disease Startup, Vir Biotech 01/06/17 San Francisco
First Clinical Trial Done, Elysium Lands $20M for Health Supplements 12/06/16 New York
Unity Bio Wants To “Lengthen Health Span,” But 1st Goals More Modest 02/03/16 San Francisco
With New CEO, Seattle’s Faraday Pharma Aims to Exploit Ikaria Roots 09/03/15 Seattle
Here’s The Agenda for Seattle Biotech Seizes The Momentum, May 6 04/20/15 Seattle
ARCH Venture Exploits IPO Window To Raise $400M Fund, Its Eighth 08/27/14 Seattle
Who Needs Biotech VCs, Anyway? 07/15/14 San Francisco
Just 7 Tickets Left for Our What’s Hot in Cancer Event April 22 04/21/14 Seattle
Join Xconomy for ‘What’s Hot in Cancer Immunotherapy’ on April 22 02/20/14 Seattle
The Young and Proven Biotech VCs From 2012. Where Are They Now? 02/10/14 National
Sage Therapeutics Nabs $20M Series B From Third Rock, Arch 10/16/13 Boston
Top 20 Under-the-Radar Trends in Innovation 05/30/13 National
Syros, a Whitehead and Dana-Farber Spinoff, Snags $30M For Cancer 04/11/13 Boston
See Clay Siegall, Kim Popovits, Mitch Gold This Afternoon 04/09/13 Seattle
Sprint, Amazon, BigDoor, Giant Thinkwell: The One-Minute Week in Seattle Tech Headlines 09/13/11 Seattle
American Innovators Lose Big in Newly Passed Patent Bill 09/09/11 National
Larry Corey, Virus Hunter With Midwest Roots, Seeks to Unleash Health Innovation at Hutch 08/02/10 Seattle
Kristina Burow, Arch’s Rising Star in SF, Spots Big Ideas in Biotech, Cleantech 07/16/10 San Francisco
Ikaria, Developer of the Hutch’s Hibernation-on-Demand Concept, Seeks $200M IPO 05/13/10 Seattle
Arch’s Nelsen Joins NVCA Board 05/05/10 Seattle
VCs On Politics: Officials Who Say They Love Innovation Are Actually Suffocating It 03/17/10 Seattle
Top Five Innovations to Watch in the Coming Decade 01/07/10 Seattle
Allozyne Advances Toward Clinic, Sonosite Boots CFO, Leroy Hood’s Common Thread With Tupac, & More Seattle-Area Life Sciences News 10/17/08 Seattle
Arch, In an Earlier Warning, Told Companies To Buckle Down, Brace For the Worst 10/15/08 Seattle
Ikaria Developing Drug For “Hibernation-on-Demand,” Could Pull Off Biggest Biotech IPO Ever, VC Says 09/02/08 Seattle
University of Washington Hires Entrepreneur to Run Tech Transfer 06/24/08 Seattle
Page 1 of 1